PACE 2023 Antibacterial Therapeutics Funding Call
Pathways to Antimicrobial Clinical Efficacy (PACE) has opened a new call for proposals: 2023 Antibacterial Therapeutics Funding Call
PACE is looking to help create and advance an exciting and diverse pipeline of preclinical phase projects aimed at treating bacterial infections with high unmet need.
With this aim their first funding call will focus solely on early-stage, novel, antibacterial therapeutics.
Up to 12 applicants will be awarded a maximum of £1 million in grant funding, with projects expected to last up to two years.
AMR innovators worldwide are eligible to apply.
Expressions of interest are invited by 24 November.